Invention Library

Cancer Screening Corporation & the ClariMark Lung Cancer Screening Test

The ClariMark test allows detection of early stage lung cancer at the point when it is most treatable.  This test is a proprietary immunoassay on blood that screens for the presence of elevated levels of specific cancer biomarkers associated with an increased incidence of lung cancer. Clinical studies have demonstrated that blood levels of these biomarkers are elevated in all types and stages of lung cancer.